Monitoring Tamoxifen Response in Rat Tumors
Author Information
Author(s): S. Baluch, C.J. Midwood, J.R. Griffiths, M. Stubbs, R.C. Coombe
Primary Institution: CRC Biomedical Magnetic Resonance Research Group, St. George's Hospital Medical School
Hypothesis
Can Magnetic Resonance Spectroscopy (MRS) be used to monitor the response of NMU-induced rat mammary tumors to tamoxifen treatment?
Conclusion
Only 42% of the tumors responded to tamoxifen treatment, with significant changes in metabolic ratios observed before any detectable change in tumor volume.
Supporting Evidence
- 42% of tumors showed significant regression after tamoxifen treatment.
- Changes in the NTP/Pi ratio were observed as early as 2 days after treatment.
- The study suggests MRS could be a rapid indicator of tumor response to therapy.
Takeaway
This study looked at how well a drug called tamoxifen works on tumors in rats, finding that some tumors got smaller while others did not change or grew bigger.
Methodology
Rats with NMU-induced tumors were treated with tamoxifen and monitored using NMR spectroscopy over 28 days.
Potential Biases
Potential bias due to the small sample size and the sensitivity of the rats to anesthesia.
Limitations
The study was conducted on a small sample size of rats, and results may not directly translate to human patients.
Participant Demographics
Female virgin Ludwig/Wistar/Olac rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website